Shares of Sun Pharmaceutical Industries on Friday tumbled nearly 6 per cent after the company reported a 20 per cent year-on-year decline in consolidated net profit for the first quarter ended June 30, 2025.
Extending its previous day’s decline, the company’s stock tanked 5.70 per cent to ₹1,608.30 on the BSE.
At the NSE, it dropped 5.78 per cent to ₹1,608.
Shares of Sun Pharmaceutical Industries had on Thursday fell by nearly 2 per cent.
Sun Pharmaceutical Industries on Thursday reported a 20 per cent year-on-year decline in consolidated net profit to ₹2,279 crore for the first quarter ended June 30, 2025.
The Mumbai-based drug major posted a net profit of ₹2,836 crore for the April-June quarter of the last financial year.
Adjusted net profit, excluding the exceptional items, for the first quarter stood at ₹2,996 crore, up 6 per cent year-on-year.
Total income rose to ₹14,316 crore for the June quarter against ₹13,185 crore in the year-ago period, Sun Pharma said in a regulatory filing.
Published on August 1, 2025